Clinical study of bronchial wall area proportion in children and adolescents based on CT images Authors: Leitao Wen, Cong Shen, Yuedong Han, Xiu’e Wang Published: 2026 ABSTRACT AbstractObjectiveThis study aims to elucidate the distribution and characteristics of bronchial wall area proportion (WA%), defined as [average wall area / (average wall area + average lumen area)], in the lungs of healthy Chinese children and adolescents aged 0–18 years.MethodsIn this cross-sectional retrospective study, chest CT scans from 795 healthy children and adolescents (482 males [61%], 313 females [39%]) aged 0–18 years were analyzed. Participants were stratified into 19 age-specific groups based on sex. Bronchial structures were automatically identified and quantified using a digital pulmonary tracheal branch measurement tool, enabling comprehensive assessment of WA% across all lung segments in the study population.ResultsWA% showed a negative correlation with age in bronchial generations beyond the second airway branch across the pediatric population. This trend was more pronounced in males than females. No significant sex differences in WA% were observed across most age groups (0–15 years, P > 0.05). However, significant differences emerged from age 16 onward in the trachea (generation 0), lung lobes, and upper bronchi (generations 1–2/3), with males consistently exhibiting lower WA% values compared to females (P < 0.05).ConclusionIn children and adolescents aged 0–18 years, bronchial WA% decreases with age. From age 16 onward, sex differences become evident, with males showing lower WA% in the trachea, lung lobes, and upper bronchi compared to females. These findings provide baseline reference data for bronchial wall characteristics in healthy pediatric populations.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s12890-026-04436-3.Keywords: Normal children and adolescents, Normal chest CT, Automatic measurement, Bronchial WA% Introduction The quantitative study of bronchial structure is critical for understanding respiratory health and disease evaluation. Establishing normative data on bronchial wall area percentage (WA%) in healthy populations serves as a fundamental baseline for diagnosing and assessing bronchial diseases. Quantification of bronchial structure allows for the early detection of pathological changes, which often precede clinical symptoms, and can significantly aid in early diagnosis and preventative measures for conditions such as asthma and chronic obstructive pulmonary disease (COPD). Furthermore, monitoring bronchial wall thickness and morphology provides valuable insights into disease progression and severity, facilitating more accurate long-term follow-up and individualized treatment plans. Additionally, quantitative assessments of bronchial changes post-treatment are essential for evaluating therapeutic efficacy and optimizing clinical decision-making. Therefore, comprehensive studies quantifying bronchial structures across all age groups, particularly in healthy children and adolescents, are crucial for improving the understanding of respiratory health and advancing the clinical management of bronchial diseases. Consequently, this study retrospectively collected chest CT images from 795 healthy children and adolescents aged 0–18 years, with CT scans interpreted as normal by radiologists, showing no abnormalities in lung structure or volume. Although lung volumes at the time of scanning varied due to age and cooperation levels, the focus on wall area percentage (WA%), a ratio of bronchial wall area to total bronchial area, minimizes the impact of these variations on measurements. Research suggests that WA% is less sensitive to lung volume changes compared to absolute bronchial measurements, as it normalizes for airway size, ensuring comparability across developmental stages [1]. Utilizing the “Digital Lung Platform” tracheobronchial measurement tool, the bronchi were automatically detected and measured to obtain the quantitative index WA% for each subject. Given the rapid growth and diverse physical development stages of children and adolescents, bronchial data indices vary significantly across different ages. This paper explores and analyzes the correlation between WA%, a quantitative bronchial index, and various age groups and sex categories, highlighting the differences observed between these demographic segments. Patients and methods Data sources A total of 795 children and adolescents aged 0–18 years who underwent normal chest CT examinations at the Imaging Department of our hospital from September 2020 to December 2023 were retrospectively analyzed in this study. These CT examinations were initially performed for various clinical indications, such as suspected respiratory infections, congenital anomalies, or trauma. However, only those scans that were confirmed to have normal findings by radiological reports were retrospectively included in this study to establish baseline data for healthy individuals. The study population comprised 482 males (61%) and 313 females (39%). The current study was approved by the Ethics Committee of Xi’an Gaoxin Hospital. All procedures involving human participants were performed in accordance with the Declaration of Helsinki (2013 revision) and relevant national guidelines. Written informed consent was obtained from all adult participants included in this study. For participants under the age of 16, informed consent was obtained from their parents or legal guardians. Inclusion criteria Children and adolescents with normal chest CT examinations and no other developmental disorders. Children and adolescents with normal chest CT examinations and no other developmental disorders. Age between 0 and 18 years. Age between 0 and 18 years. Adequate nutritional development. Adequate nutritional development. Exclusion criteria Chest CT scans that did not fully encompass both lungs. Chest CT scans that did not fully encompass both lungs. Poor respiratory coordination and substandard image quality, assessed using a standardized scoring system evaluating motion artifacts (e.g., blurring, double contours) and lung inflation adequacy [2]. Scans with a quality score < 2 (on a 5-point Likert scale) were excluded to ensure measurement accuracy [3]. Moreover, it was assessed visually by radiologists and via Dexin-FACT software quality control metrics (CT Image Quality). Poor respiratory coordination and substandard image quality, assessed using a standardized scoring system evaluating motion artifacts (e.g., blurring, double contours) and lung inflation adequacy [2]. Scans with a quality score < 2 (on a 5-point Likert scale) were excluded to ensure measurement accuracy [3]. Moreover, it was assessed visually by radiologists and via Dexin-FACT software quality control metrics (CT Image Quality). Grouping: Participants were categorized into 19 age-specific groups based on sex, corresponding to each individual year from 0 to 18 years (Table 1 and supplementary Figure S1). Table 1Statistics of age groups and numbers of children and adolescents by sexGroups (years old)0123456789101112131415161718Number of people (n)Male1442333630171214141113914183737363956Female11362321131317109139713181321162129Total25785657433029242324221627365058526085 Statistics of age groups and numbers of children and adolescents by sex Detection method and scanning parameters Chest multi-slice computed tomography (MSCT) volume data were acquired using a Philips Brilliance 256iCT scanner (Philips Healthcare, Best, Netherlands). For younger children, full-volume supine chest MSCT scans were performed from the lung apex to the lung base during calm breathing; some of these children required sedation to remain still during the procedure. Prior to scanning, older children received training to ensure proper breathing techniques and were positioned supinely. They were instructed to perform full-volume chest MSCT scans from the thoracic inlet to 1 cm below the costophrenic angle at the end of a deep inspiration. The scanning parameters were set with a tube voltage ranging from 80 to 100 kV and a tube current between 30 and 100 mA, adjusted according to the age and body size of each participant to optimize image quality and minimize radiation exposure. Given that CT scans were performed for clinical indications, all scans were re-evaluated by a senior pediatric radiologist to confirm the absence of abnormalities. Only those scans deemed free of any pathologic findings were included in the study, ensuring that all data came from children with normal, healthy chest CTs. This dual-level review process for confirming “normal” CT status is in line with the ethical and clinical guidelines for pediatric imaging, ensuring that CT scans were used only when clinically necessary, in accordance with the “ALARA” (as low as reasonably achievable) principle for radiation safety. Image post-processing and extraction of the two lungs and their bronchi The chest MSCT volume data of the studied children and adolescents were imported into the Dexin-FACT digital lung tracheobronchial measurement tool for post-processed. Using a three-dimensional boundary adaptive algorithm [4], the entire lung, including the right and left lungs, was segmented. Interlobar fissures were identified through the application of a geometric algorithm [5] and an implicit surface function algorithm [6]. Following segmentation, the lung tissue was visualized. Subsequently, the bronchial skeleton at all hierarchical levels within both lungs was extracted using a skeleton extraction algorithm, thereby forming a comprehensive three-dimensional bronchial tree structure. The image illustration is provided in the supplementary figure S2 and S3. Definition of bronchial tubes in both lungs The software categorizes bronchi at all hierarchical levels based on their generation. In this study, airway generations were defined as follows: the trachea is designated generation 0; the left and right main bronchi (originating from the tracheal bifurcation) are generation 1. Subsequent generations are assigned sequentially after each bifurcation (e.g., lobar bronchi = generation 2, segmental bronchi = generation 3). This nomenclature aligns with standardized airway classification systems adapted for pediatric populations [25], though modified to account for anatomical variations in branching patterns. Bronchial data measurement method Utilizing the digital lung tracheobronchial measurement tool, the WA% for each bronchial generation in both lungs is automatically calculated. The tool measures both the outer bronchial diameter (from the outer wall boundary) and inner luminal diameter (from the inner wall boundary) using cross-sectional orthogonal reconstructions. These measurements are used to compute the average wall area and lumen area, with WA% derived as (Average Wall Area) / (Average Wall Area + Average Lumen Area) × 100. This ratio, widely used in airway remodeling studies [26], quantifies the relative contribution of the wall to total bronchial cross-sectional area. The tool measures both the outer bronchial diameter (from the outer wall boundary) and inner luminal diameter (from the inner wall boundary) using cross-sectional orthogonal reconstructions. These measurements are used to compute the average wall area and lumen area. Selection of WA% statistics for each lobe of the lungs Statistical analysis was performed on the bronchial WA% for specific generations within each lung lobe. The selected generations for each lobe (e.g., 0–3 in the right upper lobe, 0–6 in the right lower lobe) reflect anatomical differences in bronchial branching patterns and technical detection limits. Upper lobes terminate earlier with fewer generations due to their smaller size and shorter bronchial pathways, whereas lower lobes exhibit more extensive branching, consistent with established morphometric models [7]. Additionally, smaller airways in upper lobes (beyond generation 3–4) often fall below the spatial resolution of clinical CT scanners (0.5–1.0 mm), limiting reliable detection [8]. These criteria ensure consistent and reproducible measurements across participants. Validation of the measurement tool The Dexin-FACT digital lung tracheobronchial measurement tool has undergone extensive validation and is FDA-cleared for clinical use, as well as approved by the Chinese FDA. The software’s performance has been rigorously evaluated, demonstrating high reproducibility and accuracy in measuring bronchial dimensions, including wall thickness and luminal area. In validation studies, the tool’s measurements of airway wall thickness and lumen size were found to agree closely with those of expert manual measurements and have been shown to provide highly consistent results across different operators. In addition, the system’s automated nature reduces operator bias, ensuring that measurements are obtained objectively and consistently. Furthermore, we conducted a manual cross-check of a subset of cases where bronchial measurements obtained by the software were compared to manual estimates, and no significant discrepancies were found. This validation process enhances confidence in the tool’s accuracy and ensures that it is suitable for analyzing normal bronchial dimensions in pediatric populations. Statistical methods Statistical analyses were conducted using SPSS version 22.0. The relationship between bronchial WA% and age was assessed using Spearman’s correlation analysis, with the strength of correlation categorized as follows: weak (r < 0.3), low (0.3 ≤ r < 0.5), moderate (0.5 ≤ r < 0.8), and high (r > 0.8) [9, 10]. For pairwise comparisons between groups of the same age but different genders, the independent samples t-test was employed if the data adhered to a normal distribution. In cases where the data did not follow a normal distribution, the Mann-Whitney U test was utilized. A p-value of less than 0.05 was considered indicative of a statistically significant difference. Results Correlation between age and WA% of bronchus of each generation in both lungs The bronchial WA% of the trachea (generation 0), right main bronchus (generation 1), left main bronchus (generation 1), right middle segmental bronchus (generation 2), lobe-level bronchi of both lungs (generation 2 or 3), and segmental-level bronchi and below (generation 3/4–6) in children and adolescents aged 0–18 years exhibited a weak to moderately negative correlation with age. Specifically, in males, the correlation coefficients ranged from r = -0.162 to r = -0.47 (p < 0.05), while in females, the coefficients ranged from r = -0.174 to r = -0.294 (p < 0.05). Overall, the strength of the correlation between bronchial WA% and age was more pronounced in males compared to females. These correlations are detailed in Table 2. Table 2Correlation between WA% of bronchi in each generation of both lungs and ageLeafletGenderGeneration 0 rGeneration 0 p1 r1 p2 r2 p3 r3 p4 r4 p5 r5 p6 r6 pWA% rangeUpper lobe of right lung(Generation 0–3)Male-0.502< 0.001-0.468< 0.001-0.301< 0.001-0.127< 0.001------0.228–0.436;Upper lobe of right lung(Generation 0–3)Female-0.305< 0.001-0.300< 0.001-0.154< 0.001-0.0300.465------0.215–0.395;Middle lobe of right lung(Generation 0–4)Male-0.502< 0.001-0.468< 0.001-0.301< 0.001-0.127< 0.001-0.0600.197----0.228–0.436;Middle lobe of right lung(Generation 0–4)Female-0.305< 0.001-0.300< 0.001-0.154< 0.001-0.0300.4650.0500.366----0.215–0.395;Lower lobe of right lung(Generation 0–6)Male-0.502< 0.001-0.468< 0.001-0.301< 0.001-0.127< 0.001-0.0600.197-0.2610.001-0.1720.0650.228–0.436Lower lobe of right lung(Generation 0–6)Female-0.305< 0.001-0.300< 0.001-0.154< 0.001-0.0300.4650.0500.366-0.1370.149-0.0850.4500.215–0.395;Upper lobe of left lung(Generation 0–4)Male-0.502< 0.001-0.468< 0.001-0.301< 0.001-0.127< 0.001-0.0600.197----0.228–0.436;Upper lobe of left lung(Generation 0–4)Female-0.305< 0.001-0.300< 0.001-0.154< 0.001-0.0300.4650.0500.366----0.215–0.395;Lower lobe of left lung(Generation 0–6)Male-0.502< 0.001-0.468< 0.001-0.301< 0.001-0.127< 0.001-0.0600.197-0.2610.001-0.1720.0650.228–0.436;Lower lobe of left lung(Generation 0–6)Female-0.305< 0.001-0.300< 0.001-0.154< 0.001-0.0300.4650.0500.366-0.1370.149-0.0850.4500.215–0.395 Correlation between WA% of bronchi in each generation of both lungs and age Comparison of bronchial WA% by age and generation The bronchial WA% of children and adolescents aged 0 to 18 years was analyzed across different age groups and bronchial generations, yielding the following results (Tables S1-S5 and Figs. 1, 2 and 3). There were no significant differences in bronchial WA% between males and females within any age group from 0 to 15 years (p > 0.05). In the age range of 16 to 18 years, significant differences in WA% were observed between males and females in the trachea (generation 0), both lung lobes, and bronchi above the lobes (generations 1–2/3) (p < 0.05). Specifically, males exhibited lower WA% compared to females in these regions. Within the sublobar bronchi of the 16 to 18-year-old groups, significant gender differences in WA% were identified only in specific bronchial generations: Wall area percentage (WA%) of generation 0–3 bronchi in the right upper lobe by sex among children and adolescents aged 0–18 years Wall area percentage (WA%) of bronchus in the middle lobe of the right lung by sex among children and adolescents aged 0–18 years Wall area percentage (WA%) of 3rd–6th generation bronchi in the right lower lobe by sex among children and adolescents aged 0–18 years. Note: The number of airway generations shown for each lobe corresponds to the typical bronchial tree structure of that lobe, as outlined in the methods section Right Upper Lobe: 3rd generation in 18-year-olds Right Upper Lobe: 3rd generation in 18-year-olds Left Lower Lobe: 4th generation in 17-year-olds and 3rd generation in 18-year-olds Left Lower Lobe: 4th generation in 17-year-olds and 3rd generation in 18-year-olds In these instances, males had significantly lower WA% than females (p < 0.05). However, for other sublobar bronchi below the two lung lobes (generations 3/4–6) within the 16 to 18-year-old age groups, no significant differences in bronchial WA% were observed between males and females (p > 0.05). These findings highlight age- and generation-specific variations in bronchial WA% between genders, particularly emerging in late adolescence. To assess potential asymmetry between lungs, we compared WA% between the right and left main bronchi (generation 1) across the entire cohort. The mean WA% of the right main bronchus was 31.6% ± 3.5%, while that of the left main bronchus was 34.0% ± 4.4%. Discussion Quantitative assessment of bronchial parameters, such as wall thickness, lumen diameter, lumen area, and WA%, is crucial for evaluating airway conditions in diseases like COPD and asthma [11–15]. Researchers such as Dudurych et al., [16] have posited that WA% provides a more comprehensive evaluation of bronchial health compared to measuring wall thickness alone. Alterations in WA% have been associated with the efficacy of pharmacological treatments, indicating its potential as a biomarker for assessing treatment responsiveness [17, 18]. While most bronchial research focuses on adult populations, there is a significant gap in understanding the quantitative analysis of bronchial structures in healthy children and adolescents. Our study establishes age- and sex-specific WA% reference values for children and adolescents, addressing a critical gap in respiratory diagnostics. These normative data serve as differentiating pathological airway thickening (e.g., in cystic fibrosis or asthma) from normal growth-related changes [19], enabling early detection of subclinical airway remodeling in at-risk populations [20], and providing objective benchmarks to assess treatment response, such as bronchodilator efficacy or anti-inflammatory interventions [21]. For instance, WA% thresholds derived from healthy cohorts could aid in identifying early-stage bronchial thickening in asymptomatic children, as demonstrated in pediatric asthma cohorts where WA% elevations correlate with symptom severity [22]. This study reveals a progressive decline in WA% with age across both sexes (males: r=-0.162 to -0.471, p < 0.05; female: r= -0.174 to -0.294, p < 0.05), indicating that luminal expansion outpaces wall thickening during childhood. Further examination of the age-related trends in WA% reveals a non-linear pattern, suggesting that bronchial development occurs in distinct phases. Specifically, WA% exhibits a rapid decline from ages 0 to 6 years, a more gradual decline from 6 to 12 years, and stabilization from 12 to 18 years. This phased development likely corresponds to the stages of lung maturation, where early childhood is characterized by rapid airway growth and alveolarization, middle childhood by continued but slower growth, and adolescence by near-completion of lung development [23–25]. These observations are consistent with established knowledge of human lung development, where the majority of alveolar formation occurs in the first few years of life, with further maturation extending into adolescence [26]. No significant differences in WA% were observed between males and females in any bronchial generation among children and adolescents aged 0 to 15 years (p > 0.05). However, in the 16 to 18-year age group, significant differences emerged in the trachea (generation 0), left and right main bronchi (generation 2), and bronchi at the lobe level (generations 2 or 3), with males exhibiting lower WA% compared to females (p < 0.05), aligning with findings from Wu Boyun et al. [27], which reported statistically significant lower WA% in males than in females (p < 0.05). This divergence coincides with puberty, a period marked by significant hormonal changes. Research suggests that sex hormones, particularly testosterone, influence airway structure, with higher testosterone levels in males associated with reduced airway resistance and potentially larger airway lumens. Additionally, studies indicate that sex differences in airway size emerge during puberty, likely driven by hormonal factors [7, 28]. Differences in physical activity levels between males and females may also contribute, though evidence directly linking physical activity to WA% is limited. These factors likely underlie the observed sex differences in WA% in late adolescence. Furthermore, some studies, particularly in veterinary medicine, have proposed using the ratio of bronchial wall thickness to the diameter of the adjacent pulmonary artery as an alternative measure of bronchial wall thickening [29]. This ratio aims to normalize wall thickness measurements across varying airway sizes, potentially offering a complementary perspective on airway pathology. However, in human research, WA% is more commonly employed and has been extensively validated for assessing airway remodeling in conditions such as asthma and COPD [30]. WA% directly quantifies the proportion of the airway occupied by the wall, providing a standardized metric that is less influenced by variations in airway caliber. Future research could explore the correlation between WA% and the wall thickness to artery ratio to determine if these metrics provide complementary information for the assessment of airway diseases in humans. While this study provides normative WA% data for healthy children, establishing cut-off values to distinguish normal from abnormal WA% requires comparison with diseased populations. Studies have reported elevated WA% in children with asthma compared to healthy controls (Bronchial Thickening in Asthma; Bronchial Wall Parameters), indicating that deviations from the normative values reported here may suggest airway remodeling. However, specific diagnostic thresholds have not been established. The data presented can serve as a reference for future research to define clinically relevant cut-off values. Its retrospective design may introduce selection bias and limit causal inferences. The sample size for some age groups was relatively small, potentially reducing statistical power and generalizability. The absence of height and weight data precluded analysis of anthropometric influences on WA%. Additionally, lung volume was not measured, which may confound WA% measurements, as lung size could affect bronchial dimensions. Future studies should incorporate lung volume assessments to clarify its impact on WA%. Additionally, while our study provides overall correlation coefficients between WA% and age, these may not fully capture the phase-specific trends observed. Given the cross-sectional nature of our data, we are unable to track individual changes over time. Future longitudinal studies could provide deeper insights into how WA% evolves within each developmental phase, offering a more comprehensive understanding of airway maturation during childhood and adolescence. In summary, the Wall Area Percentage (WA%) of bronchial tubes in both lung segments and higher generations decreases with age among children and adolescents aged 0 to 18 years. The correlation between bronchial WA% and age is more pronounced in males than in females. Notably, starting at age 16, significant differences in WA% between males and females emerge in the trachea (generation 0) and in the bronchi of both lung lobes and higher generations (generations 1–2/3), with males consistently exhibiting lower WA% compared to females. Supplementary Information Supplementary Material 1. Fig. S1 Statistics of age groups and numbers of children and adolescents by sex. Supplementary Material 2. Fig. S2 and S3 Measurements of the right and left lower lobe bronchus (Generation 2) in a 9-year-old: (A) Quantitative measurement values at the viewpoint location. WA% is not displayed here and is exported as an Excel table. (B) Straightened image of the left lower lobe bronchus, with the vertical red line marking the measurement location corresponding to the viewpoint; (C) Bronchial tree with the red dot indicating the viewpoint (location of left lower lobe bronchus, Generation 2); (D) Positioning of the viewpoint in axial, coronal, and sagittal planes. Supplementary Material 3. Supplementary Material 4. Supplementary Material 5. Supplementary Material 6. Supplementary Material 7. Supplementary Material 8. Acknowledgements Not applicable. Authors’ contributions Conceptualization: L.W., X.W.; Data Curation: L.W., Y.H., X.W.; Formal Analysis: L.W., C.S., X.W.; Funding Acquisition: X.W.; Investigation: Y.H., X.W.; Methodology: L.W., X.W.; Project Administration: X.W.; Resources: Y.H., X.W.; Software: C.S., X.W.; Supervision: L.W., Y.H.; Validation: L.W., C.S.; Visualization: Y.H., X.W.; Writing – Original Draft: L.W., C.S.; Writing – Review & Editing: Y.H., X.W. Funding This research received no external funding. Data availability The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate The current study was approved by the Ethics Committee of Xi’an Gaoxin Hospital. All procedures involving human participants were performed in accordance with the Declaration of Helsinki (2013 revision) and relevant national guidelines. Written informed consent was obtained from all adult participants included in this study. For participants under the age of 16, informed consent was obtained from their parents or legal guardians. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Supplementary Material 1. Fig. S1 Statistics of age groups and numbers of children and adolescents by sex. Supplementary Material 2. Fig. S2 and S3 Measurements of the right and left lower lobe bronchus (Generation 2) in a 9-year-old: (A) Quantitative measurement values at the viewpoint location. WA% is not displayed here and is exported as an Excel table. (B) Straightened image of the left lower lobe bronchus, with the vertical red line marking the measurement location corresponding to the viewpoint; (C) Bronchial tree with the red dot indicating the viewpoint (location of left lower lobe bronchus, Generation 2); (D) Positioning of the viewpoint in axial, coronal, and sagittal planes. Supplementary Material 3. Supplementary Material 4. Supplementary Material 5. Supplementary Material 6. Supplementary Material 7. Supplementary Material 8. Data Availability Statement The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.